Abstract
Development and maintenance of penile erection requires the relaxation of the smooth muscle cells in the cavernous bodies and is essentially mediated by nitric oxide (NO). The penile flaccid state is conversely maintained by the alpha adrenergic neuroeffector system and by other vasoconstrictors, such as endothelin-1 (ET-1). In this study we examined the mechanisms involved in yohimbine-induced relaxation in human and rabbit corpora cavernosa (CC). We essentially found that yohimbine not only blocks contractions induced by adrenergic agonists, but also by non-adrenergic substances, such as ET-1. This effect was unrelated to antagonism at the level of ET receptors, because yohimbine did not affect ET-1-induced increase in intracellular calcium in isolated CC cells. Conversely, our data suggest that yohimbine counteracts ET-1-induced contractions by interfering with NO release from the endothelium. In fact, yohimbine-induced CC relaxation was inhibited by the mechanical removing of the endothelium and by blocking NO formation or signalling via guanylate cyclase and cGMP formation. Conversely, yohimbine activity was strongly increased by inhibiting cGMP degradation. In an experimental model of hypogonadism, performed on rabbits by chronic treatment with a long-lasting GnRH agonist, the relaxant yohimbine activity was also decreased, but completely restored by androgen supplementation. This effect was evident only in preparations in which the main source of NO was present (endothelium) or in which NO formation was not impaired by L-NAME. Our data indicate that the relaxant effect of yohimbine is both endothelium and androgen-dependent. This might justify the lack of efficacy of this drug in treatment of some form of organic erectile dysfunction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andersson KE, Wagner G . Physiology of penile erection Pharmacol Review 1995 75: 191–236
Maggi M et al. Erectile dysfunction: from biochemical pharmacology to advances in medical therapy Eur J Endocrinol 2000 143: 143–154
Ignarro LJ et al. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle Biochem Biophys Res Comm 1990 170: 843–850
Boolell M, Gepi-Attee S, Gingell JC, Allen MJ . Sildenafil, a novel effective oral therapy for male erectile dysfunction Br J Urol 1996 78: 257–261
Traish AM, Kim NN, Goldstein I, Moreland RB . Alpha-adrenergic receptors in the penis: identification, characterization, and physiological function J Andr 1999 20: 671–682
Langez SZ et al. Role of alpha1-adrenoceptors in the future treatment of urological diseases Eur Urol 1999 36: 66–67
Becker AJ et al. Pharmacological therapy of erectile dysfunction Der Urol Ausg A 1998 37: 503–508
Hunner M . A practical treatise on disorders of the sexual function of the male and female FA Davis: Philadelphia 1926
Webb DJ, Freestone S, Allen MJ, Muirhead GJ . Sildenafil citrate and blood-pressure-lowering drugs: result of drug interaction studies with an organic nitrate and a calcium antagonist Am J Cardiol 1999 83: 21C–28C
Morales A . Yohimbine in erectile dysfunction: the facts Int J Impot Res 2000 12: S70–S74
Bevilacqua K, Barad D, Youchah J, Witt B . Is affect associated with infertility treatment outcome? Fertil Steril 2000 73: 648–649
Lue TF . Erectile dysfunction New Engl J Med 2000 342: 1802–1813
Ernst E, Pittler MH . Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials J Urol 1998 159: 433–436
Goldberg MR, Robertson D . Yohimbine: a pharmacological probe for study of the α2 adrenoreceptor Pharmacol Rev 1983 35: 143–180
Riley AJ, Goodman RE, Kellet JM, Orr R . Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy J Sex Marital Ther 1989 4: 17–26
Sonda LP, Mazo R, Chancellor MB . The role of yohimbine for the treatment of erectile impotence J Sex Marital Ther 1990 1: 15–21
Riley AJ . Local pharmacotherapy for impotence Br J Clin Pract 1993 47: 118–119
Clark J, Smith E, Davidson J . Enhancement of sexual motivation in male rats by yohimbine Science 1984 225: 847–848
Sala M et al. Central effect of yohimbine on sexual behaviour in the rat Physiol Behav 1990 47: 165–173
Rodriguez-Manzo G . Yohimbine interacts with the dopaminergic system to reverse sexual satiation: further evidence for a role of sexual motivation in sexual exhaustion Eur J Pharm 1999 372: 1–8
Quintin L et al. Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry. III. Evidence for the existence of an alpha 2-adrenergic tonic inhibition in behaving rats Brain Res 1986 375: 235–245
Vogt HJ . Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction Int J Impot Res 1997 9: 155–161
Rowland DL, Kallan K, Slob AK . Yohimbine, erectile capacity, and sexual response in men Arch Sex Behav 1997 26: 49–62
Langer S . Presynaptic regulation of catecholamine release Biochem Pharmacol 1974 23: 1793–1800
Starke K, Taube HD, Browski E . Presynaptic receptor systems in catecholaminergic transmission Biochem Pharmacol 1977 26: 259–268
Hedlund H, Andersson KE . Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery J Aut Pharm 1985 5: 81–88
Saenz De Tejada I et al. Regulation of adrenergic activity in penile corpus cavernosum J Urol 1989 142: 1117–1121
Christ GJ, Maayani S, Valcic M, Melman A . Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in α-adrenoceptor responsiveness with age and disease in isolated tissues Br J Pharmacol 1990 101: 375–381
Traish AM, Moreland RB, Huang YH, Goldstein I . Expression of functional alpha2-adrenergic receptor subtypes in human corpus cavernosum and in cultured trabecular smooth muscle cells Recept Signal Transduct 1997 7: 55–67
Gupta S et al. The expression of functional postsynaptic α2-adrenoceptors in the corpus cavernosum smooth muscle Br J Pharmacol 1998 123: 1237–1245
Steers WD, Mcconnell J, Benson GS . Some pharmacological effects of yohimbine on human and rabbit penis J Urol 1984 131: 799–802
Saenz De Tejada I et al. Design and evaluation of nitrosylated α-adrenergic receptor antagonists as potential agents for the treatment of impotence J Pharmacol Exp Ther 1999 290: 121–128
Traish A et al. Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms Int J Impot Res 1998 10: 215–223
Mills TM, Stopper VS, Reilly CM . Sites of androgenic regulation of cavernosal blood pressure during penile erection in the rat Int J Impot Res 1996 8: 29–34
Reilly CM, Zamorano P, Stopper VS, Mills TM . Androgenic regulation of NO availability in rat penile erection J Androl 1997 18: 110–115
Saenz De Tejada I et al. Cholinergic neurotrasmission in human corpus cavernosum. I. Responses of isolated tissue Am J Physiol 1988 254: H459–467
Itoh Y et al. Cloning and sequence analysis of cDNA enconding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin FEBS Lett 1988 231: 440–444
Hosoda K et al. Cloning and expression of human endothelin-1 receptor cDNA FEBS Lett 1991 287: 23–26
Ogawa Y et al. Molecular cloning of a non-isopeptide selective human endothelin receptor Biochem Biophys Res Commun 1991 178: 248–255
Ercolani L, Florence B, Denaro M, Alexander M . Isolation and complete sequence of a functional human glyceraldehydes-3-phosphate dehydrogenase gene J Biol Chem 1988 263: 15335–15341
Maggi M et al. Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A Cancer Res 1994 54: 4777–4784
Grynkiewicz G, Poenie M, Tsien RY . A generation of a Ca2+ indicators with greatly improved fluorescence properties J Biol Chem 1985 260: 3440–3450
Motulsky HJ, Ransnas LA . Fitting curves to data using nonlinear regression: a practical and nonmathematical review FASEB J 1987 1: 365–374
Garthwaite J et al. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one Mol Pharmacol 1995 48: 184–188
Traish AM et al. Effects of castration and androgen replacement on erectile function in a rabbit model Endocrinology 1999 140: 1861–1868
Sturgill MG et al. Yohimbine elimination in normal volunteers is characterized by both one-and two-compartment behavior J Cardiovasc Pharmacol 1997 29: 697–703
Kunelius P, Hakkinen J, Lukkarinen O . Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence? A prospective, randomized, controlled double-blind crossover study Urology 1997 49: 441–444
Teloken C . Therapeutics effects of high dose yohimbine hydrochloride on organic erectile dysfunction J Urol 1998 159: 122–124
Tam SW, Worcel M, Wyllie M . Yohimbine: a clinical review Pharmacol Ther 2001 91: 215–243
Chamness SL et al. The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat Fertil Steril 1995 63: 1101–1107
Marin R, Escrig A, Abreu P, Mas M . Androgen-dependent nitric oxide release in rat penis correlates with levels of constitutive nitric oxide synthase isoenzymes Biol Reprod 1999 61: 1012–1016
Lugg JA, Gonzalez-Cadavid NF, Rajfer J . The role of nitric oxide in erectile function J Androl 1995 16: 2–4
Acknowledgements
We thank Dr Clara Crescioli (Department of Clinical Physiopathology, Endocrinology Unit, University of Florence) for cell cultures, Dr Elisabetta Baldi (Department of Clinical Physiopathology, Andrology Unit, University of Florence) for technical assistance in calcium measurement and Dr Monica Muratori (Department of Clinical Physiopathology, Andrology Unit, University of Florence) for technical assistance in testosterone measurements.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Filippi, S., Luconi, M., Granchi, S. et al. Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation. Int J Impot Res 14, 295–307 (2002). https://doi.org/10.1038/sj.ijir.3900890
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3900890
Keywords
This article is cited by
-
Sexual function in men undergoing androgen deprivation therapy
International Journal of Impotence Research (2021)
-
The use of nutraceuticals in male sexual and reproductive disturbances: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)
Journal of Endocrinological Investigation (2017)
-
Relaxant effect and possible mechanism of 17-nor-subincanadine E in rabbit corpora cavernosa
Asian Journal of Andrology (2011)
-
Yohimbine relaxes the human corpus cavernosum through a non-adrenergic mechanism involving the activation of K+ATP-dependent channels
International Journal of Impotence Research (2009)
-
Which patients with sexual dysfunction are suitable for testosterone replacement therapy?
Journal of Endocrinological Investigation (2007)